Overview

Use of Intravenous Ferric Carboxymaltose in Treatment of Anemia in Cancer Patients Undergoing Chemotherapy

Status:
Completed
Trial end date:
2017-12-31
Target enrollment:
Participant gender:
Summary
This study is a nonrandomized, single arm, open-label study stratified by iron-deficiency status.
Phase:
N/A
Details
Lead Sponsor:
King Hussein Cancer Center
Collaborator:
Hikma Pharmaceuticals LLC
Treatments:
Ferric Compounds